Prospects of induced pluripotent stem cell technology in regenerative medicine

Tissue Engineering - Part B: Reviews

Volumn 17, Issue 2, 2011, Pages 115-124

  Zhang, Feng ^a   Citra, Fudiman ^a   Wang, Dong An ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINEAGE; DRUG DISCOVERY; ECTOPIC EXPRESSIONS; EMBRYONIC CELLS; EX-VIVO; IMMUNE REJECTION; IN-CELL; PLURIPOTENCY; PLURIPOTENT; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; SOMATIC CELLS;

STEM CELLS;

TRANSCRIPTION FACTORS;

ARTICLE; CELL DIFFERENTIATION; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; HUMAN; IN VITRO STUDY; MESODERM; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TISSUE REGENERATION; ANIMAL; CELL LINEAGE; CULTURE TECHNIQUE; CYTOLOGY; MOUSE; PHYSIOLOGY; PROCEDURES; REGENERATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; ECTODERM; EMBRYONIC STEM CELLS; ENDODERM; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESODERM; MICE; REGENERATION; REGENERATIVE MEDICINE;

IPS;

EID: 79953034576     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2010.0549     Document Type: Article

References (93)

1. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145, 1998.
2. Takahashi, K., and Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663, 2006.
3. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861, 2007.
4. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I., and Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917, 2007.
5. Lowry, W.E., Richter, L., Yachechko, R., Pyle, A.D., Tchieu, J., Sridharan, R., Clark, A.T., and Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105, 2883, 2008.
6. Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W., and Daley, G.Q. Repro-gramming of human somatic cells to pluripotency with defined factors. Nature 451, 141, 2008.
7. Selvaraj, V., Plane, J.M., Williams, A.J., and Deng, W. Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends Biotechnol 28, 214, 2010.
8. Das, A.K., and Pal, R. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications. J Tissue Eng Regen Med 4, 413, 2010.
9. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K., and Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell 134, 877, 2008.
10. Lee, G., and Studer, L. Induced pluripotent stem cell technology for the study of human disease. Nat Methods 7, 25, 2010.
11. Gunaseeli, I., Doss, M.X., Antzelevitch, C., Hescheler, J., and Sachinidis, A. Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Curr Med Chem 17, 759, 2010.
12. Chamberlain, S.J., Li, X.J., and Lalande, M. Induced plurip-otent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics 9, 227, 2008.
13. Tanaka, T., Tohyama, S., Murata, M., Nomura, F., Kaneko, T., Chen, H., Hattori, F., Egashira, T., Seki, T., Ohno, Y., Koshimizu, U., Yuasa, S., Ogawa, S., Yamanaka, S., Yasuda, K., and Fukuda, K. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun 385, 497, 2009.
14. Yokoo, N., Baba, S., Kaichi, S., Niwa, A., Mima, T., Doi, H., Yamanaka, S., Nakahata, T., and Heike, T. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun 387, 482, 2009.
15. Heng, B.C., Richards, M., Shu, Y., and Gribbon, P. Induced pluripotent stem cells: a new tool for toxicology screening? Arch Toxicol 83, 641, 2009.
16. Li, W., Wang, D., Qin, J., Liu, C., Zhang, Q., Zhang, X., Yu, X., Lahn, B.T., Mao, F.F., and Xiang, A.P. Generation of functional hepatocytes from mouse induced pluripotent stem cells. J Cell Physiol 222, 492, 2010.
17. Tateishi, K., He, J., Taranova, O., Liang, G., D'Alessio, A.C., and Zhang, Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 283, 31601, 2008.
18. Lu, M., Kardel, M.D., O'Connor, M.D., and Eaves, C.J. Enhanced generation of hematopoietic cells from human he-patocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp Hematol 37, 924, 2009.
19. Li, F., Bronson, S., and Niyibizi, C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem 109, 643, 2010.
20. Tashiro, K., Inamura, M., Kawabata, K., Sakurai, F., Yama-nishi, K., Hayakawa, T., and Mizuguchi, H. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 27, 1802, 2009.
21. Ebihara, K., Masuzaki, H., and Nakao, K. Long-term leptin-replacement therapy for lipoatrophic diabetes. N Engl J Med 351, 615, 2004.
22. Taura, D., Noguchi, M., Sone, M., Hosoda, K., Mori, E., Okada, Y., Takahashi, K., Homma, K., Oyamada, N., In-uzuka, M., Sonoyama, T., Ebihara, K., Tamura, N., Itoh, H., Suemori, H., Nakatsuji, N., Okano, H., Yamanaka, S., and Nakao, K. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett 583, 1029, 2009.
23. Choi, K.D., Yu, J., Smuga-Otto, K., Salvagiotto, G., Rehrauer, W., Vodyanik, M., Thomson, J., and Slukvin, I. Hemato-poietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559, 2009.
24. Lengerke, C., Grauer, M., Niebuhr, N.I., Riedt, T., Kanz, L., Park, I.H., and Daley, G.Q. Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci 1176, 219, 2009.
25. Niwa, A., Umeda, K., Chang, H., Saito, M., Okita, K., Ta-kahashi, K., Nakagawa, M., Yamanaka, S., Nakahata, T., and Heike, T. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1( + ) hemoangiogenic progenitors. J Cell Physiol 221, 367, 2009.
26. Lei, F., Haque, R., Weiler, L., Vrana, K.E., and Song, J. T lineage differentiation from induced pluripotent stem cells. Cell Immunol 260, 1, 2009.
27. Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., Yamanaka, S., and Yamashita, J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498, 2008.
28. Morizane, R., Monkawa, T., and Itoh, H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun 390, 1334, 2009.
29. Xie, C.Q., Huang, H., Wei, S., Song, L.S., Zhang, J., Ritchie, R.P., Chen, L., Zhang, M., and Chen, Y.E. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev 18, 741, 2009.
30. Kuzmenkin, A., Liang, H., Xu, G., Pfannkuche, K., Eichhorn, H., Fatima, A., Luo, H., Saric, T., Wernig, M., Jaenisch, R., and Hescheler, J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J 23, 4168, 2009.
31. Karumbayaram, S., Novitch, B.G., Patterson, M., Umbach, J.A., Richter, L., Lindgren, A., Conway, A.E., Clark, A.T., Goldman, S.A., Plath, K., Wiedau-Pazos, M., Kornblum, H.I., and Lowry, W.E. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27, 806, 2009.
32. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C.E., and Eggan, K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218, 2008.
33. Buchholz, D.E., Hikita, S.T., Rowland, T.J., Friedrich, A.M., Hinman, C.R., Johnson, L.V., and Clegg, D.O. Derivation of functional retinal pigmented epithelium from induced plu-ripotent stem cells. Stem Cells 27, 2427, 2009.
34. Hirami, Y., Osakada, F., Takahashi, K., Okita, K., Yamanaka, S., Ikeda, H., Yoshimura, N., and Takahashi, M. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 458, 126, 2009.
35. Osakada, F., Jin, Z.B., Hirami, Y., Ikeda, H., Danjyo, T., Watanabe, K., Sasai, Y., and Takahashi, M. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 122, 3169, 2009.
36. Moretti, A., Bellin, M., Jung, C.B., Thies, T.M., Takashima, Y., Bernshausen, A., Schiemann, M., Fischer, S., Moosmang, S., Smith, A.G., Lam, J.T., and Laugwitz, K.L. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1 + cardiovascular progenitors. FASEB J 24, 700, 2010.
37. Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., Du-Mouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J.Q., Eidelberg, D., and Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344, 710, 2001.
38. Kim, J.H., Auerbach, J.M., Rodriguez-Gomez, J.A., Velasco, I., Gavin, D., Lumelsky, N., Lee, S.H., Nguyen, J., Sanchez-Pernaute, R., Bankiewicz, K., and McKay, R. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50, 2002.
39. Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., and Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 105, 5856, 2008.
40. Shi, Q., Fahs, S.A., Kuether, E.L., Cooley, B.C., Weiler, H., and Montgomery, R.R. Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A. Blood 116, 3049, 2010.
41. Xu, D., Alipio, Z., Fink, L.M., Adcock, D.M., Yang, J., Ward, D.C., and Ma, Y. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci USA 106, 808, 2009.
42. Ye, L., Chang, J.C., Lin, C., Sun, X., Yu, J., and Kan, Y.W. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 106, 9826, 2009.
43. Hanna, J., Wernig, M., Markoulaki, S., Sun, C.W., Meissner, A., Cassady, J.P., Beard, C., Brambrink, T., Wu, L.C., Townes, T.M., and Jaenisch, R. Treatment of sickle cell anemia mouse model with iPS cells generated from autolo-gous skin. Science 318, 1920, 2007.
44. Wada, H.K.S., Okamoto, N., Satoh, Y., Ishizuka, B., and Seino, K. Successful differentiation to T cells, but unsuccessful B cell generation, from B-cell-derived induced plu-ripotent stem cells. Int Immonol 23, 65, 2011.
45. Coffey, P.J., Girman, S., Wang, S.M., Hetherington, L., Keegan, D.J., Adamson, P., Greenwood, J., and Lund, R.D. Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci 5, 53, 2002.
46. Lund, R.D., Wang, S., Klimanskaya, I., Holmes, T., Ramos-Kelsey, R., Lu, B., Girman, S., Bischoff, N., Sauve, Y., and Lanza, R. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8, 189, 2006.
47. Lawrence, J.M., Sauve, Y., Keegan, D.J., Coffey, P.J., He-therington, L., Girman, S., Whiteley, S.J., Kwan, A.S., Pheby, T., and Lund, R.D. Schwann cell grafting into the retina of the dystrophic RCS rat limits functional deterioration. Royal College of Surgeons. Invest Ophthalmol Vis Sci 41, 518, 2000.
48. Inoue, Y., Iriyama, A., Ueno, S., Takahashi, H., Kondo, M., Tamaki, Y., Araie, M., and Yanagi, Y. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 85, 234, 2007.
49. Wang, S., Girman, S., Lu, B., Bischoff, N., Holmes, T., Shearer, R., Wright, L.S., Svendsen, C.N., Gamm, D.M., and Lund, R.D. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci 49, 3201, 2008.
50. Thumann, G., Salz, A.K., Walter, P., and Johnen, S. Preservation of photoreceptors in dystrophic RCS rats following allo- and xenotransplantation of IPE cells. Graefes Arch Clin Exp Ophthalmol 247, 363, 2009.
51. Carr, A.J., Vugler, A.A., Hikita, S.T., Lawrence, J.M., Gias, C., Chen, L.L., Buchholz, D.E., Ahmado, A., Semo, M., Smart, M.J., Hasan, S., da Cruz, L., Johnson, L.V., Clegg, D.O., and Coffey, P.J. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 4, e8152, 2009.
52. Sommer, C.A., Stadtfeld, M., Murphy, G.J., Hochedlinger, K., Kotton, D.N., and Mostoslavsky, G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543, 2009.
53. Chang, C.W., Lai, Y.S., Pawlik, K.M., Liu, K., Sun, C.W., Li, C., Schoeb, T.R., and Townes, T.M. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fi-broblasts to induced pluripotent stem cells. Stem Cells 27, 1042, 2009.
54. Carey, B.W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitalipova, M., and Jaenisch, R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA 106, 157, 2009.
55. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K., and Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85, 348, 2009.
56. Zhou, W., and Freed, C.R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667, 2009.
57. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., and Hoche-dlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945, 2008.
58. Okita, K., Hong, H., Takahashi, K., and Yamanaka, S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 5, 418, 2010.
59. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., and Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949, 2008.
60. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., and Thomson, J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797, 2009.
61. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., Siuzdak, G., Scholer, H.R., Duan, L., and Ding, S. Generation of induced plurip-otent stem cells using recombinant proteins. Cell Stem Cell 4, 381, 2009.
62. Ichida, J.K., Blanchard, J., Lam, K., Son, E.Y., Chung, J.E., Egli, D., Loh, K.M., Carter, A.C., Di Giorgio, F.P., Koszka, K., Huangfu, D., Akutsu, H., Liu, D.R., Rubin, L.L., and Eggan, K. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491, 2009.
63. Lyssiotis, C.A., Foreman, R.K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L.L., Charette, B.D., Bouchez, L.C., Bollong, M., Kunick, C., Brinker, A., Cho, C.Y., Schultz, P.G., and Jaenisch, R. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 106, 8912, 2009.
64. Li, W., Zhou, H., Abujarour, R., Zhu, S., Young Joo, J., Lin, T., Hao, E., Scholer, H.R., Hayek, A., and Ding, S. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992, 2009.
65. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., and Melton, D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26, 1269, 2008.
66. Feng, B., Jiang, J., Kraus, P., Ng, J.H., Heng, J.C., Chan, Y.S., Yaw, L.P., Zhang, W., Loh, Y.H., Han, J., Vega, V.B., Cacheux-Rataboul, V., Lim, B., Lufkin, T., and Ng, H.H. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 11, 197, 2009.
67. Utikal, J., Maherali, N., Kulalert, W., and Hochedlinger, K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122, 3502, 2009.
68. Kim, J.B., Greber, B., Arauzobravo, M.J., Meyer, J., Park, K.I., Zaehres, H., and Scholer, H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649, 2009.
69. Tsai, S.Y., Clavel, C., Kim, S., Ang, Y.S., Grisanti, L., Lee, D.F., Kelley, K., and Rendl, M. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells. Stem Cells 28, 221, 2010.
70. Giorgetti, A., Montserrat, N., Rodriguez-Piza, I., Azqueta, C., Veiga, A., and Izpisua Belmonte, J.C. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat Protoc 5, 811, 2010.
71. Kim, J.B., Sebastiano, V., Wu, G., Arauzobravo, M.J., Sasse, P., Gentile, L., Ko, K., Ruau, D., Ehrich, M., van den Boom, D., Meyer, J., Hubner, K., Bernemann, C., Ortmeier, C., Zenke, M., Fleischmann, B.K., Zaehres, H., and Scholer, H.R. Oct4-induced pluripotency in adult neural stem cells. Cell 136, 411, 2009.
72. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., Natesan, S., Wagers, A.J., Melnick, A., Evans, T., and Hochedlinger, K. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28, 848, 2010.
73. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M.J., Ji, H., Ehrlich, L.I., Yabuuchi, A., Takeuchi, A., Cunniff, K.C., Hongguang, H., McKinney-Freeman, S., Na-veiras, O., Yoon, T.J., Irizarry, R.A., Jung, N., Seita, J., Hanna, J., Murakami, P., Jaenisch, R., Weissleder, R., Orkin, S.H., Weissman, I.L., Feinberg, A.P., and Daley, G.Q. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285, 2010.
74. Hwang, S.T., Kang, S.W., Lee, S.J., Lee, T.H., Suh, W., Shim, S.H., Lee, D.R., Taite, L.J., Kim, K.S., and Lee, S.H. The expansion of human ES and iPS cells on porous membranes and proliferating human adipose-derived feeder cells. Biomaterials 31, 8012, 2010.
75. Ezashi, T., Telugu, B.P., Alexenko, A.P., Sachdev, S., Sinha, S., and Roberts, R.M. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci USA 106, 10993, 2009.
76. Araki, R., Jincho, Y., Hoki, Y., Nakamura, M., Tamura, C., Ando, S., Kasama, Y., and Abe, M. Conversion of ancestral fibroblasts to induced pluripotent stem cells. Stem Cells 28, 213, 2010.
77. Sun, N., Panetta, N.J., Gupta, D.M., Wilson, K.D., Lee, A., Jia, F., Hu, S., Cherry, A.M., Robbins, R.C., Longaker, M.T., and Wu, J.C. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106, 15720, 2009.
78. Lagarkova, M.A., Shutova, M.V., Bogomazova, A.N., Vassina, E.M., Glazov, E.A., Zhang, P., Rizvanov, A.A., Chestkov, I.V., and Kiselev, S.L. Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle 9, 937, 2010.
79. Eminli, S., Foudi, A., Stadtfeld, M., Maherali, N., Ahfeldt, T., Mostoslavsky, G., Hock, H., and Hochedlinger, K. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 41, 968, 2009.
80. Takenaka, C., Nishishita, N., Takada, N., Jakt, L.M., and Kawamata, S. Effective generation of iPS cells from CD34 + cord blood cells by inhibition of p53. Exp Hematol 38, 154, 2010.
81. Kunisato, A., Wakatsuki, M., Kodama, Y., Shinba, H., Ishida, I., and Nagao, K. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev 19, 229, 2010.
82. Loh, Y.H., Agarwal, S., Park, I.H., Urbach, A., Huo, H., Heffner, G.C., Kim, K., Miller, J.D., Ng, K., and Daley, G.Q. Generation of induced pluripotent stem cells from human blood. Blood 113, 5476, 2009.
83. Chang, M.Y., Kim, D., Kim, C.H., Kang, H.C., Yang, E., Moon, J.I., Ko, S., Park, J., Park, K.S., Lee, K.A., Hwang, D.Y., Chung, Y., Lanza, R., and Kim, K.S. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One 5, e9838, 2010.
84. Kim, J.B., Zaehres, H., Wu, G., Gentile, L., Ko, K., Sebastiano, V., Arauzobravo, M.J., Ruau, D., Han, D.W., Zenke, M., and Scholer, H.R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646, 2008.
85. Do, J.T., Joo, J.Y., Han, D.W., Arauzobravo, M.J., Kim, M.J., Greber, B., Zaehres, H., Sobek-Klocke, I., Chung, H.M., and Scholer, H.R. Generation of parthenogenetic induced plu-ripotent stem cells from parthenogenetic neural stem cells. Stem Cells 27, 2962, 2009.
86. Kim, J.B., Zaehres, H., Arauzobravo, M.J., and Scholer, H.R. Generation of induced pluripotent stem cells from neural stem cells. Nat Protoc 4, 1464, 2009.
87. Stadtfeld, M., Brennand, K., and Hochedlinger, K. Repro-gramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18, 890, 2008.
88. Balasubramanian, S., Babai, N., Chaudhuri, A., Qiu, F., Bhattacharya, S., Dave, B.J., Parameswaran, S., Carson, S.D., Thoreson, W.B., Sharp, J.G., Rao, M., and Ahmad, I. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors. Stem Cells 27, 3053, 2009.
89. Guan, K., Nayernia, K., Maier, L.S., Wagner, S., Dressel, R., Lee, J.H., Nolte, J., Wolf, F., Li, M., Engel, W., and Hasenfuss, G. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440, 1199, 2006.
90. Golestaneh, N., Kokkinaki, M., Pant, D., Jiang, J., DeStefano, D., Fernandez-Bueno, C., Rone, J.D., Haddad, B.R., Gallicano, G.I., and Dym, M. Pluripotent stem cells derived from adult human testes. Stem Cells Dev 18, 1115, 2009.
91. Conrad, S., Renninger, M., Hennenlotter, J., Wiesner, T., Just, L., Bonin, M., Aicher, W., Buhring, H.J., Mattheus, U., Mack, A., Wagner, H.J., Minger, S., Matzkies, M., Reppel, M., He-scheler, J., Sievert, K.D., Stenzl, A., and Skutella, T. Generation of pluripotent stem cells from adult human testis. Nature 456, 344, 2008.
92. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Ta-kahashi, K., Chiba, T., and Yamanaka, S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699, 2008.
93. Yan, X., Qin, H., Qu, C., Tuan, R.S., Shi, S., and Huang, G.T. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 19, 469, 2010.